General Information of This Drug (ID: DM1N62C)

Drug Name
Quetiapine   DM1N62C
Synonyms
quetiapine; 111974-69-7; Quetiapine [INN:BAN]; UNII-BGL0JSY5SI; BGL0JSY5SI; CHEMBL716; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; CHEBI:8707; C21H25N3O2S; URKOMYMAXPYINW-UHFFFAOYSA-N; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol; Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-; NCGC00095911-03; Co-Quetiapine; Norsic; Quetiapina; Quetiapinum; Quetiapine hemifumarate; Ketipinor (TN); Norsic (TN); Quetiapine (INN); Seroquel (Fumarate); Seroquel (TN); 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol; 2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol; PD-172760
Indication
Disease Entry ICD 11 Status REF
Anorexia nervosa cachexia 6B80 Approved [1]
Bipolar depression N.A. Approved [1]
Bipolar disorder 6A60 Approved [1]
Bipolar I disorder N.A. Approved [1]
Delirium N.A. Approved [1]
Major depressive disorder 6A70.3 Approved [1]
Methamphetamine dependence 6C46.2 Approved [1]
Schizoaffective disorder 6A21 Approved [1]
Schizophrenia 6A20 Approved [2]
Alcohol dependence 6C40.2 Phase 3 [3]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Antipsychotic Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

6 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Quetiapine + Aripiprazole DCXCB60 Aripiprazole Schizophrenia [4]
Quetiapine + Paroxetine DCF9I9G Paroxetine Combat Disorders [5]
Quetiapine + Aripiprazole DCR2A8B Aripiprazole Schizophrenia [6]
Quetiapine + Risperidone DCC5U45 Risperidone Bipolar Disorder [7]
Quetiapine + Risperidone DCCGTQH Risperidone Schizophrenia [8]
Sertraline + Quetiapine DC542KP Sertraline Major Depressive Disorder With Psychotic Features [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DrugCom(s)

References

1 Quetiapine FDA Label
2 The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
3 ClinicalTrials.gov (NCT02362412) Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes. U.S. National Institutes ofHealth.
4 ClinicalTrials.gov (NCT01164059) Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
5 ClinicalTrials.gov (NCT00292370) Quetiapine Augmentation for Treatment-resistant PTSD
6 ClinicalTrials.gov (NCT01129674) A Long-Term, Open-Label, Study on Schizophrenia
7 ClinicalTrials.gov (NCT02562287) Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
8 ClinicalTrials.gov (NCT00423878) Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
9 ClinicalTrials.gov (NCT00955474) Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms